Drug Shortage Report for GAMMAGARD S/D
| Report ID | 202833 |
| Drug Identification Number | 02231470 |
| Brand name | GAMMAGARD S/D |
| Common or Proper name | Immunoglobulin Intravenous (Human) |
| Company Name | TAKEDA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IMMUNOGLOBULIN |
| Strength(s) | 5G |
| Dosage form(s) | KIT SOLUTION POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 100 mL Vial |
| ATC code | J06BA |
| ATC description | IMMUNOGLOBULINS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2023-08-23 |
| Actual start date | 2023-08-23 |
| Estimated end date | 2023-09-30 |
| Actual end date | 2023-09-13 |
| Shortage status | Resolved |
| Updated date | 2023-09-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-09-14 | English | Compare |
| v5 | 2023-09-13 | French | Compare |
| v4 | 2023-09-13 | English | Compare |
| v3 | 2023-08-23 | French | Compare |
| v2 | 2023-08-23 | English | Compare |
| v1 | 2023-08-23 | English | Compare |
Showing 1 to 6 of 6